scholarly article | Q13442814 |
P50 | author | Lauren M.F. Merlo | Q30530341 |
Philip Gerrish | Q42842789 | ||
Kathleen Sprouffske | Q88494847 | ||
P2093 | author name string | Carlo C Maley | |
Paul D Sniegowski | |||
P2860 | cites work | The population genetics of dN/dS | Q21145026 |
Animal cell differentiation patterns suppress somatic evolution | Q21145656 | ||
Genetic predisposition to cancer — insights from population genetics | Q22122022 | ||
Microbial genetics: Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation | Q22122024 | ||
Cancer as an evolutionary and ecological process | Q22122026 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis | Q24602426 | ||
A comprehensive catalogue of somatic mutations from a human cancer genome | Q24628532 | ||
Complex landscapes of somatic rearrangement in human breast cancer genomes | Q24631412 | ||
Efficient tumour formation by single human melanoma cells | Q24648938 | ||
The basics of epithelial-mesenchymal transition | Q24652992 | ||
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing | Q24653015 | ||
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia | Q27851726 | ||
Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
A genetic model for colorectal tumorigenesis | Q27860582 | ||
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice | Q27860831 | ||
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 | ||
Lethal Mutagenesis: Targeting the Mutator Phenotype in Cancer | Q35669158 | ||
Problems of somatic mutation and cancer | Q35677655 | ||
Complete genetic linkage can subvert natural selection | Q35748721 | ||
Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution | Q35811223 | ||
Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection | Q35818681 | ||
Clonal architecture of secondary acute myeloid leukemia | Q35872658 | ||
Clonal interference in large populations | Q36156834 | ||
Virus dynamics and drug therapy | Q36244920 | ||
Comparative lesion sequencing provides insights into tumor evolution | Q36670136 | ||
Fitness consequences of a regulatory polymorphism in a seasonal environment | Q36689750 | ||
Chromosome fragility: molecular mechanisms and cellular consequences | Q36849639 | ||
Optimizing drug exposure to minimize selection of antibiotic resistance | Q36903693 | ||
Clonal interference, multiple mutations and adaptation in large asexual populations | Q37011413 | ||
Oncogene addiction | Q37152445 | ||
The fixation probability of rare mutators in finite asexual populations. | Q37152739 | ||
Self-generated diversity produces "insurance effects" in biofilm communities | Q37621081 | ||
Population biological principles of drug-resistance evolution in infectious diseases | Q37849394 | ||
Exploring the genomes of cancer cells: progress and promise | Q37857590 | ||
Genome-wide approaches to the study of adaptive gene expression evolution: systematic studies of evolutionary adaptations involving gene expression will allow many fundamental questions in evolutionary biology to be addressed | Q37871502 | ||
Selection and neutrality in lactose operons of Escherichia coli | Q38343258 | ||
The balance between mutators and nonmutators in asexual populations | Q38517985 | ||
Tests of parallel molecular evolution in a long-term experiment with Escherichia coli | Q34694847 | ||
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing | Q34812680 | ||
Deletion at fragile sites is a common and early event in Barrett's esophagus. | Q35002032 | ||
Accurate reconstruction of the temporal order of mutations in neoplastic progression | Q35091312 | ||
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy | Q35092451 | ||
Production of resistant HIV mutants during antiretroviral therapy | Q35165357 | ||
Distinguishing driver and passenger mutations in an evolutionary history categorized by interference | Q35542057 | ||
Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma | Q35577877 | ||
Proliferation of mutators in A cell population | Q35618973 | ||
Emergent neutrality in adaptive asexual evolution | Q35620493 | ||
Bacterial biofilms: a common cause of persistent infections | Q27861033 | ||
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice | Q28131777 | ||
Dynamics of adaptation and diversification: a 10,000-generation experiment with bacterial populations | Q28245607 | ||
Selforganization of matter and the evolution of biological macromolecules | Q28248277 | ||
Asymmetric and symmetric stem-cell divisions in development and cancer | Q28249478 | ||
Cancer stem cells: mirage or reality? | Q28257690 | ||
The clonal evolution of tumor cell populations | Q28271546 | ||
Cancer genes and the pathways they control | Q28275089 | ||
The origin of mutants | Q28288915 | ||
Molecular definition of breast tumor heterogeneity | Q28292256 | ||
Adaptive protein evolution at the Adh locus in Drosophila | Q28302478 | ||
Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies | Q28471733 | ||
Pervasive Cryptic Epistasis in Molecular Evolution | Q28475868 | ||
Tumour evolution inferred by single-cell sequencing | Q28646966 | ||
Real time forecasting of near-future evolution | Q28728760 | ||
Peto's Paradox: evolution's prescription for cancer prevention | Q28741797 | ||
Lethal mutagenesis of bacteria | Q28756839 | ||
The Evolution of Mutation Rate in Finite Asexual Populations | Q29301497 | ||
Clonal evolution in cancer | Q29547696 | ||
Patterns of somatic mutation in human cancer genomes | Q29547841 | ||
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 | ||
Detection of mutations in EGFR in circulating lung-cancer cells | Q29615033 | ||
Darwinian evolution can follow only very few mutational paths to fitter proteins | Q29616042 | ||
The hypercycle. A principle of natural self-organization. Part A: Emergence of the hypercycle | Q29616074 | ||
THE RELATION OF RECOMBINATION TO MUTATIONAL ADVANCE | Q29616118 | ||
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database | Q29616468 | ||
The patterns and dynamics of genomic instability in metastatic pancreatic cancer | Q29618121 | ||
The clonal and mutational evolution spectrum of primary triple-negative breast cancers | Q29619914 | ||
Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors | Q31096211 | ||
(A)symmetric stem cell replication and cancer | Q33279153 | ||
The repertoire and dynamics of evolutionary adaptations to controlled nutrient-limited environments in yeast | Q33392677 | ||
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype | Q33604942 | ||
The role of genetic diversity in cancer | Q33604953 | ||
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. | Q33638070 | ||
Rate, molecular spectrum, and consequences of human mutation | Q33667179 | ||
Periodic selection in Escherichia coli | Q33711273 | ||
Beneficial mutations and the dynamics of adaptation in asexual populations. | Q33856627 | ||
The increasing complexity of the cancer stem cell paradigm | Q33862363 | ||
Long-Term Experimental Evolution in Escherichia coli. VIII. Dynamics of a Balanced Polymorphism | Q33888665 | ||
Drug resistance in cancer: principles of emergence and prevention | Q33892278 | ||
The evolution of mutation rates: separating causes from consequences | Q33925698 | ||
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori | Q33952076 | ||
Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coli | Q33963371 | ||
Evolutionary consequences of mutation and selection within an individual | Q33966095 | ||
Exceptional convergent evolution in a virus. | Q33971443 | ||
Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer. | Q34035601 | ||
Ribavirin's antiviral mechanism of action: lethal mutagenesis? | Q34119894 | ||
Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme | Q34189506 | ||
Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment. | Q34202519 | ||
Cooperation and conflict in the evolution of multicellularity | Q34216636 | ||
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor | Q34258285 | ||
Accumulation of driver and passenger mutations during tumor progression | Q34276850 | ||
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. | Q34307548 | ||
Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus | Q34321602 | ||
Multiple mutations and cancer | Q34327554 | ||
The speed of evolution and maintenance of variation in asexual populations | Q34330675 | ||
The mutation rate and cancer | Q34410886 | ||
Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiae | Q34415662 | ||
Evolution of high mutation rates in experimental populations of E. coli | Q34429727 | ||
Perspective: Sign epistasis and genetic constraint on evolutionary trajectories | Q34437784 | ||
The solitary wave of asexual evolution | Q34470274 | ||
Genetic clonal diversity predicts progression to esophageal adenocarcinoma | Q34505745 | ||
Mutation and epigenetic molecular clocks in cancer | Q34520423 | ||
Adaptation in sexuals vs. asexuals: clonal interference and the Fisher-Muller model | Q34589967 | ||
Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria | Q34607018 | ||
Enzyme kinetics, substitutable resources and competition: from biochemistry to frequency-dependent selection in lac. | Q34615999 | ||
Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populations. | Q34616140 | ||
The speed of adaptation in large asexual populations | Q34645731 | ||
Looking for Darwin in all the wrong places: the misguided quest for positive selection at the nucleotide sequence level | Q34648294 | ||
Interfering waves of adaptation promote spatial mixing. | Q39028906 | ||
Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm | Q39386631 | ||
Is there any genetic instability in human cancer? | Q39683908 | ||
Signatures of mutation and selection in the cancer genome | Q39737975 | ||
Diminishing returns epistasis among beneficial mutations decelerates adaptation | Q39954065 | ||
The mutational meltdown in asexual populations | Q41067565 | ||
MUTATION LOAD AND THE SURVIVAL OF SMALL POPULATIONS. | Q41176863 | ||
The traveling-wave approach to asexual evolution: Muller's ratchet and speed of adaptation | Q41853709 | ||
Epistasis and the adaptability of an RNA virus | Q41907301 | ||
Enrichment and elimination of mutY mutators in Escherichia coli populations | Q42031695 | ||
Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor | Q42033067 | ||
Spatial structure increases the waiting time for cancer. | Q42202619 | ||
Negative epistasis between beneficial mutations in an evolving bacterial population | Q44010374 | ||
The molecular diversity of adaptive convergence. | Q46185374 | ||
The McDonald-Kreitman test and slightly deleterious mutations | Q50064983 | ||
Evolutionary biology of cancer. | Q51727179 | ||
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. | Q51890946 | ||
An error catastrophe in cancer? | Q52000115 | ||
The rhythm of microbial adaptation. | Q52054921 | ||
Social strife in the microbial world. | Q52102611 | ||
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. | Q53360408 | ||
Stochastic elimination of cancer cells. | Q53374855 | ||
The fate of competing beneficial mutations in an asexual population. | Q54262235 | ||
Role of mutator alleles in adaptive evolution. | Q54564129 | ||
Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer. | Q54587349 | ||
Lineage selection and the evolution of multistage carcinogenesis. | Q55032938 | ||
Adaptive radiation in a heterogeneous environment | Q56038387 | ||
Repeated evolution of an acetate-crossfeeding polymorphism in long-term populations of Escherichia coli | Q58870925 | ||
Relative fitness can decrease in evolving asexual populations of S. cerevisiae | Q59051577 | ||
Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populations | Q59092867 | ||
THE ADAPTATION RATE OF ASEXUALS: DELETERIOUS MUTATIONS, CLONAL INTERFERENCE AND POPULATION BOTTLENECKS | Q60167619 | ||
ENVIRONMENTAL HETEROGENEITY ENHANCES CLONAL INTERFERENCE | Q60167621 | ||
The accumulation of deleterious genes in a population--Muller's Ratchet | Q67444775 | ||
The population genetics of multistage carcinogenesis | Q73552224 | ||
Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia | Q83830344 | ||
Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments | Q84975610 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | experimental evolution | Q3592884 |
P304 | page(s) | R762-71 | |
P577 | publication date | 2012-09-01 | |
P1433 | published in | Current Biology | Q1144851 |
P1476 | title | Cancer in light of experimental evolution | |
P478 | volume | 22 |
Q35729697 | A Genetic Incompatibility Accelerates Adaptation in Yeast |
Q99578991 | Application of simultaneous selective pressures slows adaptation |
Q38254752 | Beyond genome sequencing: lineage tracking with barcodes to study the dynamics of evolution, infection, and cancer. |
Q28601078 | Biochemistry and physiology within the framework of the extended synthesis of evolutionary biology |
Q26767415 | Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine |
Q47313036 | Cancer Progression Models and Fitness Landscapes: a Many-to-Many Relationship |
Q34321565 | Cancer heterogeneity: implications for targeted therapeutics |
Q92963637 | Clonal evolution and genome stability in a 2500-year-old fungal individual |
Q38594523 | Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse. |
Q59125278 | Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer |
Q64078921 | DNA Damage Stress: Cui Prodest? |
Q42206019 | Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites |
Q35777228 | Evolutionary perspective of cancer: myth, metaphors, and reality |
Q57174769 | Experimental Design, Population Dynamics, and Diversity in Microbial Experimental Evolution |
Q92578371 | Fine-grained simulations of the microenvironment of vascularized tumours |
Q37696306 | First principles of Hamiltonian medicine. |
Q47294854 | Genetic drift and selection in many-allele range expansions |
Q89884665 | Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models |
Q28651650 | Genome dynamics during experimental evolution |
Q64963172 | Genomic clustering of fitness-affecting mutations favors the evolution of chromosomal instability. |
Q38724178 | Host manipulation by cancer cells: Expectations, facts, and therapeutic implications |
Q38683761 | Inferring clonal structure in HTLV-1-infected individuals: towards bridging the gap between analysis and visualization |
Q38165448 | Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications |
Q36120373 | Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach |
Q30825161 | Kinesin-5 Contributes to Spindle-length Scaling in the Evolution of Cancer toward Metastasis |
Q26766238 | Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors |
Q39047616 | Lesion-Directed Therapies and Monitoring Tumor Evolution Using Liquid Biopsies |
Q49541273 | Modeling the Subclonal Evolution of Cancer Cell Populations |
Q38762495 | Molecular evolution of colorectal cancer: from multistep carcinogenesis to the big bang |
Q28088605 | Molecular heterogeneity in glioblastoma: potential clinical implications |
Q36264128 | Multidisciplinary insight into clonal expansion of HTLV-1-infected cells in adult T-cell leukemia via modeling by deterministic finite automata coupled with high-throughput sequencing |
Q59356259 | Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma |
Q34358875 | Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations |
Q35061276 | Population dynamics of metastable growth-rate phenotypes |
Q26801291 | Protecting the normal in order to better kill the cancer |
Q47115915 | Resource competition promotes tumour expansion in experimentally evolved cancer. |
Q42416137 | Spatial Moran models, II: cancer initiation in spatially structured tissue |
Q94461588 | Synthetic hybrids of six yeast species |
Q28391909 | Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence" |
Q33763823 | The effect of population bottlenecks on mutation rate evolution in asexual populations |
Q35573684 | The reverse evolution from multicellularity to unicellularity during carcinogenesis |
Q41918920 | The shock of being united and symphiliosis. Another lesson from plants? |
Q26866803 | Tumour heterogeneity and the evolution of polyclonal drug resistance |
Q55379165 | Turning natural adaptations to oncogenic factors into an ally in the war against cancer. |
Q34387997 | Whole genome, whole population sequencing reveals that loss of signaling networks is the major adaptive strategy in a constant environment |
Search more.